Clinical Report: BiomedLoop Framework for Lung Cancer Lesion Segmentation

Overview

BiomedLoop is a novel text-driven closed loop framework that integrates semantic descriptions with spatial quantification to improve lung cancer lesion segmentation. It outperforms conventional CNN and Segment Anything Model variants by achieving higher Dice similarity coefficients and lower Hausdorff distances across multiple public datasets.

Background

Accurate segmentation of lung cancer lesions is critical for early detection and treatment planning but remains challenging due to scanner sensitivity and lack of alignment with radiologist language. Traditional segmentation methods produce pixel masks that do not correspond well with clinical reporting standards, limiting their practical utility. BiomedLoop addresses this gap by combining text-guided localization and refinement techniques, enabling outputs that mirror routine diagnostic practice and structured reporting. This approach facilitates better clinical integration, especially in resource-limited settings.

Data Highlights

Key Findings

• BiomedLoop integrates semantic text descriptions with spatial lesion quantification, aligning segmentation with radiologist language.
• It uses a fine-tuned Grounding DINO for localization and SEEM with an Uncertainty Aware Feature Modulator for boundary refinement.
• Converts mask-derived geometric descriptors into pseudo text prompts to enable training on datasets lacking native radiology reports.
• Outputs structured reports compliant with the TID 1500 specification, facilitating clinical reporting standards.
• Demonstrated superior performance across five public lung cancer imaging benchmarks compared to conventional CNNs and Segment Anything Model variants.
• Supports cross-dataset adaptation and external evaluation, enhancing generalizability and robustness.

Clinical Implications

BiomedLoop's text-driven approach bridges the gap between automated segmentation and clinical reporting, potentially improving diagnostic accuracy and workflow integration. Its ability to generate structured, standardized reports may enhance communication among clinicians and support decision-making. Furthermore, its adaptability to datasets without native reports makes it suitable for diverse clinical environments, including resource-limited settings.

Conclusion

BiomedLoop represents a significant advancement in lung cancer lesion segmentation by combining semantic understanding with spatial precision, thereby enhancing clinical relevance and utility. This framework offers a promising tool for improving early detection and treatment planning in lung cancer care.

References

1. Frija et al. 2021 -- How to improve access to medical imaging in low- and middle-income countries?
2. Hricak et al. 2021 -- Medical imaging and nuclear medicine: a Lancet Oncology Commission
3. Verduzco-Aguirre et al. 2019 -- Implementation of diagnostic resources for cancer in developing countries
4. Zhang et al. 2024 -- Interpretable machine learning model for digital lung cancer prescreening
5. Sung et al. 2021 -- Global cancer statistics 2020
6. Bray et al. 2024 -- Global cancer statistics 2022
7. Elkefi et al. 2025 -- Systematic review on the technology’s role in supporting lung cancer patients
8. Ronneberger et al. 2015 -- U-net: convolutional networks for biomedical image segmentation
9. Isensee et al. 2021 -- nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation
10. Guan & Liu 2021 -- Domain adaptation for medical image analysis: a survey
11. Zhang et al. 2020 -- Generalizing deep learning for medical image segmentation to unseen domains
12. Ouyang et al. 2022 -- Causality-inspired single-source domain generalization for medical image segmentation